{
  "meta": {
    "title": "216_Medicine_Neet_2019",
    "url": "https://brainandscalpel.vercel.app/216-medicine-neet-2019-3a5cebaa.html",
    "scrapedAt": "2025-11-30T12:57:02.725Z"
  },
  "questions": [
    {
      "text": "A 65-year-old female patient is brought to the emergency department in a state of unconsciousness. Her BP is 70/50 mm of Hg. Her ECG is shown below. What is the next best step in the management of her condition?",
      "choices": [
        {
          "id": 1,
          "text": "IV verapamil"
        },
        {
          "id": 2,
          "text": "IV adenosine"
        },
        {
          "id": 3,
          "text": "Carotid massage"
        },
        {
          "id": 4,
          "text": "DC cardioversion"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical scenario describes an <strong>unconscious patient</strong>, who is <strong>hemodynamically unstable</strong> (systolic BP &lt;90 mmHg or mean arterial pressure &lt;65 mmHg). The ECG shows a <strong>narrow QRS complex tachycardia</strong> (heart rate of 188 BPM) with <strong>regular RR interval</strong> and&nbsp;<strong>absent</strong><strong>&nbsp;P waves</strong>, characteristic of <strong>paroxysmal supraventricular tachycardia</strong> (PSVT). The next step in management is <strong>QRS-synchronized DC cardioversion.</strong></p>\n<p>Shown below is the algorithm for the management of supraventricular tachycardia:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/bc8abf258fe54dd0a7ab09a274501279x1280x1845.JPEG\" alt=\"Explanation Image\"><p>Options A, B, and C are all used in stable cases. Vagal maneuvers like carotid massage or Valsalva are tried first followed by IV Adenosine. If these are ineffective, IV Verapamil, Diltiazem, or Beta blockers are used.</p>\n<table>\n<tbody>\n<tr>\n<td>Synchronized cardioversion</td>\n<td>Defibrillation</td>\n</tr>\n<tr>\n<td>\n<p>Used in sustained VT<br />Used in <strong>SVT (unstable cases)</strong>, atrial flutter/fibrillation</p>\n</td>\n<td>Used in VT and VF without a pulse</td>\n</tr>\n<tr>\n<td>The shock delivered in <strong>sync with R wave</strong> (in absolute refractory period)</td>\n<td>The shock is delivered at any time during cardiac cycle</td>\n</tr>\n<tr>\n<td>\n<p>Characteristics of QRS complex:<br />Narrow and regular - 50 to 100J<br />Narrow and irregular - 120 to 200J<br />Wide and regular - 100J <br />Wide and irregular - No synchronised cardioversion</p>\n</td>\n<td>\n<p>Wide and irregular QRS complex <br />Monophasic: 360 J<br />Biphasic:1 20-200 J</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Supraventricular tachycardias</h3><p>&nbsp;</p>\n<p><strong>Supraventricular tachycardias with narrow QRS complex:</strong></p>\n<ul>\n<li><strong>Narrow QRS with regular RR interval</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>&nbsp; &nbsp;Tachycardia</strong></td>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;ECG features</strong></td>\n</tr>\n<tr>\n<td><strong>Sinus tachycardia</strong></td>\n<td>Normal P wave, normal ECG features except for the rate</td>\n</tr>\n<tr>\n<td><strong>Focal atrial tachycardia</strong></td>\n<td>A single type of abnormal p wave morphology is seen</td>\n</tr>\n<tr>\n<td><strong>Junctional tachycardia</strong></td>\n<td>No p waves. Heart rate is 100- 200/ min</td>\n</tr>\n<tr>\n<td><strong>AV nodal reentry tachycardia</strong></td>\n<td>No p waves. Pseudo R' waves may be seen. Heart rate is 150-250/ min</td>\n</tr>\n<tr>\n<td><strong>Atrioventricular reentry tachycardia</strong></td>\n<td>P wave always follows QRS. RP interval&lt; PR interval</td>\n</tr>\n<tr>\n<td><strong>Atrial flutter</strong></td>\n<td>Sawtooth shaped flutter waves are seen</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<ul>\n<li><strong>Narrow QRS with irregular RR interval</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>&nbsp; &nbsp; &nbsp;<strong>Tachycardia</strong></td>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp;ECG features</strong></td>\n</tr>\n<tr>\n<td><strong>Atrial fibrillation</strong></td>\n<td>No distinct p waves seen</td>\n</tr>\n<tr>\n<td><strong>Multifocal atrial tachycardia</strong></td>\n<td>More than 3 different abnormal p wave morphologies are seen</td>\n</tr>\n<tr>\n<td><strong>Atrial flutter/tachycardia with variable block</strong></td>\n<td>ECG features of heart block are seen.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Supraventricular tachycardias with wide QRS complex:</strong></p>\n<ul>\n<li>Antidromic AVRT (atrioventricular reentry tachycardia)</li>\n<li>Supraventricular tachycardias with bundle branch block</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/6edcf84b58e7436c8d29d57b32d7c111.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9096",
      "difficulty": "medium"
    },
    {
      "text": "Nasal polyps are commonly associated with:",
      "choices": [
        {
          "id": 1,
          "text": "Intrinsic asthma"
        },
        {
          "id": 2,
          "text": "Brittle asthma"
        },
        {
          "id": 3,
          "text": "Extrinsic asthma"
        },
        {
          "id": 4,
          "text": "Exercise-induced asthma"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Nasal polyps</strong> are associated with <strong>intrinsic asthma</strong>.</p>\n<p>Intrinsic asthma is characterized by the presence of <strong>asthma</strong> with <strong>negative skin prick tests</strong> for common antigens. The association of nasal polyps with asthma is described by <strong>Samter&rsquo;s triad</strong> (intrinsic asthma + aspirin hypersensitivity + nasal polyposis). Asthma is usually severe, persistent, and <strong>adult-onset</strong>.</p>\n<p>Other options:</p>\n<p>Option B: <strong>Brittle asthma</strong> refers to a <strong>severe</strong> variant of asthma where patients have very serious and often, <strong>life-threatening attacks</strong> despite appropriate therapy.</p>\n<p>Option C: <strong>Extrinsic asthma</strong> is also referred to as atopic asthma. It is <strong>allergen</strong> mediated.</p>\n<p>Option D: <strong>Exercise-induced asthma</strong> is airway narrowing due to <strong>strenuous physical activity</strong>. Symptoms typically start after the exercise has ended and last for around 30 minutes. </p><hr><h3>Related Pearl: Extrinsic vs Intrinsic asthma</h3><table>\n<tbody>\n<tr>\n<td><strong>Component</strong></td>\n<td><strong>Extrinsic asthma</strong></td>\n<td><strong>Intrinsic asthma</strong></td>\n</tr>\n<tr>\n<td>Other names</td>\n<td>Atopic/ allergic asthma</td>\n<td>Non-atopic/ non-allergic/ idiosyncratic asthma</td>\n</tr>\n<tr>\n<td>Associated with&nbsp;</td>\n<td>Atopy, drug or food allergy (past or family history)</td>\n<td>Samter&rsquo;s triad (asthma + aspirin sensitivity + sinus disease with recurrent nasal polyps)</td>\n</tr>\n<tr>\n<td>Onset</td>\n<td>Childhood</td>\n<td>Adult</td>\n</tr>\n<tr>\n<td>Inflammation</td>\n<td>Eosinophil mediated</td>\n<td>Neutrophil mediated</td>\n</tr>\n<tr>\n<td>IgE levels</td>\n<td>&uarr; IgE (type 1 hypersensitivity)</td>\n<td>Normal IgE (negative skin prick test)</td>\n</tr>\n<tr>\n<td>Most common trigger</td>\n<td>Dermatophagoides (House mite)</td>\n<td>\n<p>Superantigen -&nbsp;<br /><em>S. aureus</em> enterotoxin</p>\n</td>\n</tr>\n<tr>\n<td>Response to inhaled corticosteroids</td>\n<td>Responds well&nbsp;</td>\n<td>\n<p>Decreased short term response</p>\n</td>\n</tr>\n<tr>\n<td>Prognosis</td>\n<td>Good</td>\n<td>Bad</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9869",
      "difficulty": "medium"
    },
    {
      "text": "All of the following are AIDS defining illnesses except:",
      "choices": [
        {
          "id": 1,
          "text": "Encephalopathy attributed to HIV"
        },
        {
          "id": 2,
          "text": "Invasive cervical cancer"
        },
        {
          "id": 3,
          "text": "Mycobacterium tuberculosis of any site"
        },
        {
          "id": 4,
          "text": "Oral candidiasis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Oral candidiasis</strong>, although seen in AIDS patients, is <strong>not</strong> an <strong>AIDS-defining</strong> illness. <strong>Candidiasis</strong> of the <strong>esophagus</strong>, <strong>trachea</strong>, <strong>bronchi,</strong> and <strong>lungs</strong> are AIDS-defining illnesses.&nbsp;</p>\n<p>AIDS-defining illnesses are specific <strong>opportunistic</strong> illnesses in patients with <strong>AIDS</strong>, which signify an advanced stage of illness (<strong>Stage 3</strong>).</p>\n<p>A case of HIV can be classified into five stages as per current CDC guidelines (0, 1, 2, 3, and unknown).</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Stage</strong></p>\n</td>\n<td><strong>Criteria</strong></td>\n<td><strong>CD4+ count (&gt;5 years)</strong></td>\n</tr>\n<tr>\n<td>\n<p>0</p>\n</td>\n<td>A negative HIV test within 6 months of first diagnosis</td>\n<td>NA</td>\n</tr>\n<tr>\n<td>1</td>\n<td>Based on CD4+ count</td>\n<td>&gt;=500</td>\n</tr>\n<tr>\n<td>2</td>\n<td>Based on CD4+ count</td>\n<td>200-499</td>\n</tr>\n<tr>\n<td>3</td>\n<td><strong>AIDS-defining opportunistic illness</strong></td>\n<td>&lt;200</td>\n</tr>\n<tr>\n<td>unknown</td>\n<td>Unavailable CD4+ counts</td>\n<td>unknown</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: AIDS-defining opportunistic infections and neoplasm</h3><p><strong>Infections:</strong></p>\n<ul>\n<li><strong>Protozoal and helminthic infections-</strong>\n<ul>\n<li>Cryptosporidiosis or Isosporiasis (cystoisosporiasis) - Chronic intestinal</li>\n<li>Toxoplasmosis (pneumonia or CNS infection)</li>\n</ul>\n</li>\n<li><strong>Fungal infections-</strong>\n<ul>\n<li>Candidiasis (esophageal, tracheal, or pulmonary)</li>\n<li>Cryptococcosis (CNS infection)</li>\n<li>Coccidioidomycosis (disseminated)</li>\n<li>Pneumocystosis (pneumonia or disseminated infection)</li>\n<li>Histoplasmosis (disseminated)</li>\n</ul>\n</li>\n<li><strong>Bacterial infections-</strong>\n<ul>\n<li>Mycobacteriosis (&ldquo;atypical,&rdquo; e.g., <em>Mycobacterium avium-intracellulare</em>)&nbsp;disseminated or extrapulmonary</li>\n<li>Mycobacterium tuberculosis (pulmonary&nbsp;or extrapulmonary)</li>\n<li>Nocardiosis (pneumonia, meningitis, disseminated)</li>\n<li>Salmonella infections, disseminated</li>\n</ul>\n</li>\n<li><strong>Viral infections-</strong>\n<ul>\n<li>Cytomegalovirus (pulmonary, intestinal, retinitis, or CNS infections)</li>\n<li>Herpes simplex virus (localized or disseminated infection)</li>\n<li>Varicella-zoster virus (localized or disseminated infection)</li>\n<li>Progressive multifocal leukoencephalopathy</li>\n</ul>\n</li>\n</ul>\n<p><strong>Neoplasms:</strong></p>\n<ul>\n<li>Kaposi sarcoma</li>\n<li>Primary lymphoma of brain</li>\n<li>Invasive cancer of uterine cervix&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1418",
      "difficulty": "hard"
    },
    {
      "text": "A 47-year-old man with a diagnosis of acute myeloid leukemia with a blood type O negative blood group presents to the transplant clinic to discuss proceeding with an allogeneic stem cell transplant. Which of the following would be an optimal donor?",
      "choices": [
        {
          "id": 1,
          "text": "His identical twin brother"
        },
        {
          "id": 2,
          "text": "Umbilical cord transplant"
        },
        {
          "id": 3,
          "text": "His HLA identical 50-year-old brother who is otherwise healthy and is blood type O+"
        },
        {
          "id": 4,
          "text": "An HLA identical matched unrelated donor who is blood type O–"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In the case of acute myeloid leukemia (AML), <strong>allogeneic</strong> stem cell transplants are the <strong>treatment of choice</strong>. His<strong> HLA identical 50-year-old brother</strong> who is blood type <strong>O positive</strong> would be the <strong>best choice</strong>.</p>\n<p>Other options:</p>\n<p>Option A: An <strong>identical twin brother</strong> would <strong>not</strong> be the donor of choice. The therapeutic benefit of stem cell transplant in hematological malignancies is due to the <strong>graft-versus-leukemia (GvL)</strong>. Donor T lymphocytes attack malignant hematopoietic stem cells of the recipient that remain after high-dose chemotherapy. Despite having a <strong>low rate of graft versus host disease</strong> (GvHD), stem cells from an identical twin <strong>do not have</strong> a desirable degree of <strong>GvL effect</strong>, leading to <strong>higher</strong> rates of <strong>recurrence</strong> post-transplant.&nbsp;</p>\n<p>Option B: <strong>Autologous</strong> (umbilical cord transplant) is <strong>not recommended</strong> as <strong>higher</strong> rates of <strong>relapse</strong> have been reported.</p>\n<p>Option D: An <strong>HLA identical sibling</strong> is <strong>preferred over</strong> an <strong>unrelated HLA identical donor </strong>because there is a greater chance of matching for <strong>minor histocompatibility complex</strong> (mHC). This <strong>reduces</strong> the risk of <strong>GvHD</strong>. ABO compatibility is also important to consider, but a minor ABO mismatch (Rh mismatch) doesn't have any impact on hemolysis, graft-versus-host disease, or survival.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1700",
      "difficulty": "hard"
    },
    {
      "text": "A 30-year-old HIV-positive man presents with fever for 3 weeks, dry cough, and significant weight loss. He complains of retrosternal chest pain that is worse on inspiration. His chest X-ray is given below. What is the most likely diagnosis?\n",
      "choices": [
        {
          "id": 1,
          "text": "Staphylococcal pneumonia"
        },
        {
          "id": 2,
          "text": "Pneumococcal pneumonia"
        },
        {
          "id": 3,
          "text": "Tuberculosis"
        },
        {
          "id": 4,
          "text": "Pneumocystis jirovecii pneumonia"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The most likely diagnosis in a case of <strong>pneumonia</strong> in a <strong>HIV positive patient</strong>, along with the presence of <strong>fever</strong>, and <strong>non-productive cough</strong> with radiographic findings of <strong>diffuse interstitial infiltrates</strong> and <strong>symmetric perihilar involvement</strong> is <strong>Pneumocystis jirovecii pneumonia</strong> (PCP). A characteristic feature of PCP is <strong>retrosternal chest pain</strong>, which worsens on inspiration and is described as sharp or burning.</p>\n<p>It is important to note that even though the incidence of PCP is the <strong>highest at CD4+ counts of &lt;200/&mu;L</strong> (80%), it can be seen in <strong>patients with higher counts</strong>.</p><p>Other options:</p>\n<p>Option D: <strong>Tuberculosis</strong> (TB) should be considered as a possibility in cases of pneumonia in people living with HIV. However, the <strong>absence of hilar lymph node involvement</strong>, <strong>non-productive cough,</strong> and <strong>no extrapulmonary</strong> (pleural, pericardial, lymphatic) features are not consistent with tuberculosis.</p>\n<p>TB can occur at any stage of HIV infection. In the early stages, pulmonary TB appears typically with <strong>upper-lobe infiltrates</strong> and <strong>cavitation</strong>. In advanced HIV infection, with <strong>CD4+ T-cell count below 200/&mu;L</strong>, TB presents with <strong>diffuse interstitial infiltrates</strong>, minimal cavitation, pleural effusion, and lymphadenopathy. <strong>Extrapulmonary TB</strong> is fairly <strong>common in HIV,</strong> with it being documented in 40-60% of cases.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d075b38874ad44148e298a12b0a83e44x720x308.PNG\" alt=\"Explanation Image\"><p>Option A: <strong>Staphylococcal pneumonia</strong> most commonly presents with a <strong>productive cough</strong>, and radiologically presents with <strong>pneumatoceles</strong> (cavitations)</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1c3da642bd62464d9de3dc72d4f3c2bfx720x540.PNG\" alt=\"Explanation Image\"><p>Option B: Patients with <strong>pneumococcal pneumonia</strong> also present with fever, dyspnea, and productive cough. Imaging usually shows <strong>lobar involvement</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f2199be14db44c50be08edf2982583ebx720x573.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Typical Pneumonia  v/s  Atypical Pneumonia</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Typical pneumonia</strong>&nbsp;</span></td>\n<td><span><strong>Atypical pneumonia&nbsp;</strong></span></td>\n</tr>\n<tr>\n<td><span>Extracellular organism&nbsp;</span></td>\n<td><span>Intracellular organism</span></td>\n</tr>\n<tr>\n<td><span>Alveolar exudates in air spaces </span></td>\n<td><span>Interstitial involvement</span><br /><br /></td>\n</tr>\n<tr>\n<td><span>Neutrophilic in nature</span></td>\n<td><span>Lymphocytic in nature</span></td>\n</tr>\n<tr>\n<td><span>High-grade fever</span></td>\n<td><span>Low-grade fever</span></td>\n</tr>\n<tr>\n<td><span>Productive cough</span></td>\n<td>\n<p><span>Dry cough</span><br /><span>hemoptysis &nbsp;&nbsp;</span><span>scanty sputum</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Pleuritic chest pain </span></td>\n<td><span>Extrapulmonary manifestation</span></td>\n</tr>\n<tr>\n<td><span>X-Ray shows large areas of consolidation</span></td>\n<td><span>X-Ray shows an interstitial pattern of involvement.</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<ul>\n<li><span>The most common cause of <strong>Community-acquired Pneumonia</strong>- <em>Streptococcus pneumoniae.</em></span></li>\n<li><span>The most common cause of <strong>Atypical Pneumonia</strong>- <em>Mycoplasma&nbsp;pneumoniae.</em></span></li>\n<li><span>The most common&nbsp;cause of <strong>Nosocomial Pneumonia</strong>-</span>\n<ul>\n<li><span>Overall- gram-negative bacilli (implicated as a group)</span></li>\n<li><span>The single most common agent-&nbsp;<em>Staphylococcus aureus</em> (i.e.,&nbsp;gram-positive cocci)</span></li>\n</ul>\n</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/788eb4488f054109ae5a0d183c4128c5x1280x732.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/fe6edf02cce04da288395f5d7c1e757b.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3559",
      "difficulty": "easy"
    },
    {
      "text": "All are true about Guillain-Barre syndrome except:",
      "choices": [
        {
          "id": 1,
          "text": "Inflammatory condition"
        },
        {
          "id": 2,
          "text": "Descending paralysis is seen"
        },
        {
          "id": 3,
          "text": "Plasmapheresis is a treatment method"
        },
        {
          "id": 4,
          "text": "Demyelinating disorder"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Ascending</strong>&nbsp;(not descending)<strong>&nbsp;paralysis</strong> is seen in <strong>Guillain-Barre syndrome </strong>(GBS). It generally begins in the bilateral lower limbs (rubbery legs) affecting both proximal and distal muscles and ascends to involve the trunk and upper limbs.</p>\n<p>GBS is an acute, autoimmune, <strong>inflammatory</strong>, <strong>demyelinating</strong> polyneuropathy. The usual presentation is symmetrical, ascending paralysis evolving over hours to a few days. There is usually no progression beyond <strong>4 weeks</strong>. The legs are usually more affected than the arms. It is associated with <strong>autonomic dysfunction</strong> with or without sensory involvement. The most commonly involved cranial nerve is the&nbsp;<strong>facial nerve</strong> (50%). Lower cranial nerves are also frequently involved, causing bulbar weakness and difficulty in maintaining an airway and handling secretions.&nbsp;<strong>Deep tendon reflexes</strong> diminish or disappear within the initial days of symptom onset. <strong>Bladder dysfunction</strong> may occur in severe cases but is typically transient and <strong>not a prominent feature</strong>.</p>\n<p>70% of GBS cases occur within 1-3 weeks after an acute<strong> infectious process</strong>, commonly respiratory or gastrointestinal infections.&nbsp;<strong><em>Campylobacter jejuni</em></strong>,&nbsp;human herpes viruses, and&nbsp;<em>Mycoplasma pneumoniae&nbsp;</em> have been implicated.</p>\n<p>The diagnosis is based on <strong>Brighton criteria</strong>. It includes a combination of clinical, electrophysiologic, and CSF findings.&nbsp;<strong>Cytoalbuminologic dissociation</strong> (elevated CSF protein level AND CSF total white cell count &lt;50 cells/&mu;L) is characteristic of GBS.</p>\n<p>Treatment should ideally commence as early as possible. <strong>Intravenous immunoglobulin</strong> (2g/kg bodyweight over 5 days) and <strong>plasmapheresis</strong>&nbsp;are both viable treatment options, with similar efficacy for typical GBS. Approximately 30% of GBS patients require <strong>ventilatory assistance</strong>.&nbsp;<strong>Glucocorticoids</strong> have <strong>not shown efficacy</strong> in GBS management.</p><hr><h3>Related Pearl: Antibodies seen in Guillian Barre syndrome</h3><table>\n<tbody>\n<tr>\n<td><strong>Type</strong></td>\n<td><strong>Antibody</strong></td>\n</tr>\n<tr>\n<td>AIDP</td>\n<td>Anti GM1</td>\n</tr>\n<tr>\n<td>AMAN</td>\n<td>Anti GD1a</td>\n</tr>\n<tr>\n<td>AMSAN</td>\n<td>Anti GD1a</td>\n</tr>\n<tr>\n<td>Miller Fisher syndrome</td>\n<td>Anti GQ1b</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li>AIDP-Acute inflammatory demyelinating polyneuropathy&nbsp;</li>\n<li>AMAN-Acute motor axonal neuropathy&nbsp;</li>\n<li>AMSAN-Acute motor sensory axonal neuropathy&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2092",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is the best treatment for the relapse of immune thrombocytopenic purpura?",
      "choices": [
        {
          "id": 1,
          "text": "IV immunoglobulins"
        },
        {
          "id": 2,
          "text": "Steroids"
        },
        {
          "id": 3,
          "text": "Splenectomy"
        },
        {
          "id": 4,
          "text": "Blood transfusion"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Splenectomy</strong> is the treatment of choice in a case of <strong>immune thrombocytopenic purpura</strong> (ITP) relapse after <strong>first line therapy</strong> with <strong>glucocorticoids</strong>. The relapse usually occurs once they are tapered. <strong>Vaccination</strong> against encapsulated organisms (pneumococcus, meningococcus, H. influenzae) is advised before splenectomy is performed.</p>\n<p>It is important to note that in some patients <strong>ITP resolves by itself,</strong> and observation along with intermittent <strong>IV immunoglobulins</strong> and <strong>anti - Rh(D)</strong> administration or administration of a <strong>thrombopoietin receptor agonist</strong> (eltrombopag, romiplostim) can be a viable option before splenectomy is considered.</p>\n<p>The treatment of ITP is as follows:</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>Clinical features</td>\n<td>Management</td>\n</tr>\n<tr>\n<td>\n<p>1. &nbsp;&nbsp;</p>\n</td>\n<td>\n<p>Minor bleeding manifestations (and/or)</p>\n<p>Platelet count &gt; 5000/&nbsp;&mu;L</p>\n</td>\n<td>\n<p><strong>Prednisone</strong> (OR)</p>\n<p><strong>Anti-D immunoglobulin therapy</strong> - effective only in Rh-positive patients (OR)</p>\n<p>Intravenous immunoglobulin (IVIG)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>2. &nbsp;</p>\n</td>\n<td>\n<p>Severe ITP (any of the following):</p>\n<ul>\n<li>Significant GI / intracranial bleeding</li>\n<li>Platelet count &lt; 5000/&mu;L</li>\n<li>Signs of impending bleeding (retinal or large oral mucosal bleeds)</li>\n</ul>\n</td>\n<td>\n<p>Platelet transfusion (AND)</p>\n<p>High-dose glucocorticoids (AND)</p>\n<p>IVIG / Anti-D immunoglobulins + Rituximab</p>\n</td>\n</tr>\n<tr>\n<td>3. &nbsp;</td>\n<td>Relapse after first-line therapy</td>\n<td><strong>Splenectomy</strong></td>\n</tr>\n<tr>\n<td>4. &nbsp;&nbsp;</td>\n<td>Unresponsive to all other therapy or relapse after splenectomy</td>\n<td>Thrombopoietin receptor agonists - <strong>romiplostim</strong> (subcutaneous), <strong>eltrombopag</strong> (oral)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>ITP is an <strong>acquired</strong> disorder characterized by the <strong>immune-mediated</strong> destruction of platelets and possibly inhibition of platelet release from the megakaryocyte. Secondary causes of ITP include systemic lupus erythematosus (<strong>SLE</strong>), <strong>HIV-AIDS</strong>, and <strong>Hepatitis C</strong>.</p>\n<p>ITP usually presents with <strong>mucocutaneous bleeding</strong>, <strong>very low platelet count</strong>, and normal peripheral blood cells. Patients typically exhibit ecchymoses and petechiae or they may incidentally discover thrombocytopenia during a routine complete blood count.&nbsp;Rarely, life-threatening bleeding may occur. The presence of <strong>wet purpura</strong> (blood blisters in the mouth) and <strong>retinal hemorrhages</strong> can serve as <strong>warning signs</strong> of potentially life-threatening bleeding.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7483",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following cardiac chambers is enlarged in mitral stenosis on chest X-ray initially?",
      "choices": [
        {
          "id": 1,
          "text": "Left atrium"
        },
        {
          "id": 2,
          "text": "Right atrium"
        },
        {
          "id": 3,
          "text": "Left ventricle"
        },
        {
          "id": 4,
          "text": "Right ventricle"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Left atrium</strong> (LA) is the <strong>first cardiac chamber</strong> to get enlarged in mitral stenosis (MS). It is due to the pressure overload of LA. It can be appreciated on the lateral and left anterior oblique views.</p>\n<p>Other radiographic changes seen in MS are <strong>straightening of the upper left border</strong> of the cardiac silhouette, posterior displacement of the esophagus by an enlarged LA, and <strong>Kerley B lines</strong> due to distention of interlobular septae and lymphatics with edema.</p>\n<p><strong>Severe MS</strong> causing <strong>pulmonary hypertension</strong> leads to enlargement of the pulmonary artery, <strong>right ventricle</strong>, and <strong>right atrium</strong>. <strong>Left ventricle&nbsp;</strong>remains <strong>unaffected</strong> in isolated MS.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7505",
      "difficulty": "easy"
    },
    {
      "text": "Which among the following is false?",
      "choices": [
        {
          "id": 1,
          "text": "Components of MELD (Model for end stage liver disease) scoring system are creatinine, bilirubin, International normalized ratio (INR), serum sodium (mEq/L)."
        },
        {
          "id": 2,
          "text": "Components of CTP(Child Turcotte Pugh) score are albumin, bilirubin, INR, ascites, encephalopathy"
        },
        {
          "id": 3,
          "text": "Components of CTP (Child Turcotte Pugh ) are creatinine, bilirubin, International normalized ratio (INR)"
        },
        {
          "id": 4,
          "text": "MELD score is used to assess and prioritize patients awaiting liver transplantation"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The <strong>Child Turcotte Pugh</strong> (CTP) score <strong>does not</strong> include <strong>creatinine</strong>.</p>\n<p>The <strong>components of&nbsp;</strong>the<strong> CTP score </strong>are:</p>\n<ul>\n<li>Albumin</li>\n<li>Bilirubin</li>\n<li>International normalized ratio (INR)</li>\n<li>Ascites</li>\n<li>Encephalopathy</li>\n</ul>\n<p>The <strong>Model for End-stage liver disease</strong>&nbsp;(MELD 3.0) is used to&nbsp;<strong>prioritize patients awaiting liver transplantation&nbsp;</strong>and&nbsp;includes:</p>\n<ul>\n<li><strong>Female sex</strong></li>\n<li>Bilirubin</li>\n<li><strong>Albumin</strong></li>\n<li>Serum sodium (mEq/L)</li>\n<li>INR (International Normalized ratio)</li>\n<li>Creatinine</li>\n</ul><hr><h3>Related Pearl: Child-Turcotte-Pugh Score</h3><p>The Child&ndash;Turcotte&ndash;Pugh (CTP) score was originally developed to <strong>evaluate the risk of portocaval shunt procedures </strong>performed for<strong> portal hypertension.</strong>&nbsp;It is also useful in predicting the surgical risks of other intra-abdominal operations performed in cirrhotic patients.</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Variable</strong></p>\n</td>\n<td>\n<p><strong>1 Point</strong></p>\n</td>\n<td>\n<p><strong>2 Points</strong></p>\n</td>\n<td>\n<p><strong>3 Points</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Bilirubin level</p>\n</td>\n<td>\n<p>&lt;2 mg/dL</p>\n</td>\n<td>\n<p>2&ndash;3 mg/dL</p>\n</td>\n<td>\n<p>&gt;3 mg/dL</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Albumin level</p>\n</td>\n<td>\n<p>&gt;3.5 g/dL</p>\n</td>\n<td>\n<p>2.8&ndash;3.5 g/dL</p>\n</td>\n<td>\n<p>&lt;2.8 g/dL</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prothrombin time (increased seconds)</p>\n<p>International normalized ratio</p>\n</td>\n<td>\n<p>1&ndash;3</p>\n<p>&lt;1.7</p>\n</td>\n<td>\n<p>4&ndash;6</p>\n<p>1.7&ndash;2.3</p>\n</td>\n<td>\n<p>&gt;6</p>\n<p>&gt;2.3</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Encephalopathy</p>\n</td>\n<td>\n<p>None</p>\n</td>\n<td>\n<p>Controlled</p>\n</td>\n<td>\n<p>Uncontrolled</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ascites</p>\n</td>\n<td>\n<p>None</p>\n</td>\n<td>\n<p>Controlled</p>\n</td>\n<td>\n<p>Uncontrolled</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Child-Turcotte-Pugh class and overall surgical mortality rates:</strong></p>\n<ul>\n<li>Class A = 5&ndash;6 points - Well-compensated - 10% mortality</li>\n<li>Class B = 7&ndash;9 points - Decompensated and significant&nbsp; functional compromise - 30% mortality</li>\n<li>Class C = 10&ndash;15 points - Severerly decompensated - 75-80% mortality</li>\n</ul>\n<p><strong>Prognosis of the various CTP classes:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Class</strong></td>\n<td><strong>1-year survival rate &nbsp;%</strong></td>\n<td><strong>2-year survival rate %</strong></td>\n</tr>\n<tr>\n<td>A</td>\n<td>100</td>\n<td>85</td>\n</tr>\n<tr>\n<td>B</td>\n<td>80</td>\n<td>60</td>\n</tr>\n<tr>\n<td>C</td>\n<td>45</td>\n<td>35</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Revised Model for End-stage liver disease  (MELD) scoring system: MELD 3.0</h3><p>MELD 3.0 score has the following components (Mnemonic <strong>F BASIC</strong>)</p>\n<ul>\n<li>Female sex</li>\n<li>Bilirubin</li>\n<li>Albumin</li>\n<li>Serum sodium (mEq/L)</li>\n<li>INR (International Normalized ratio)</li>\n<li>Creatinine</li>\n</ul>\n<p><strong>Uses:</strong></p>\n<ul>\n<li>Predict short-term prognosis in patients undergoing transjugular intrahepatic portosystemic shunt (TIPS) insertion</li>\n<li>Assess and <strong>prioritize patients</strong> awaiting <strong>liver transplantation</strong></li>\n<li>Assess prognosis in cirrhosis</li>\n</ul>\n<p class=\"bulletIndent1\">&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7510",
      "difficulty": "medium"
    },
    {
      "text": "Identify the false statement about the bundle of Kent.",
      "choices": [
        {
          "id": 1,
          "text": "It is faster than AV nodal pathway"
        },
        {
          "id": 2,
          "text": "It is slower than AV nodal pathway"
        },
        {
          "id": 3,
          "text": "Leads to short PR interval"
        },
        {
          "id": 4,
          "text": "Leads to prolonged QRS duration"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The<strong> bundle of Kent</strong> is the <strong>accessory pathway</strong> of conduction between the atria and ventricle in <strong>Wolff-Parkinson-White syndrome</strong>. It conducts impulses&nbsp;<strong>faster than the AV nodal pathway</strong> and&nbsp;<strong>avoids AV nodal delay</strong>, leading to <strong>shortened PR interval</strong>. <strong>QRS is prolonged</strong>&nbsp;because of the AV nodal impulse reaching the ventricles after the aberrant impulse.</p><hr><h3>Related Pearl: Wolff Parkinson White Syndrome</h3><p><strong>Wolff Parkinson White Syndrome</strong>&nbsp;(WPW) is characterized by an abnormal accessory pathway in the heart leading to arrhythmias.</p>\n<p><strong>Pathology</strong>- Born with an accessory pathway, the bundle of Kent which connects the atria and ventricle. The electrical impulses from the SA node reach the ventricles earlier via the accessory pathway as there is no AV nodal delay in this pathway. This leads to the preexcitation of the ventricle and initiation of ventricular contraction. This ventricular contraction is prolonged when the impulse via the AV nodal pathway reaches the ventricles.</p>\n<p><strong>Most common location</strong> of the accessory pathway-&nbsp;between the left atrium and free wall of the left ventricle</p>\n<p><strong>ECG changes</strong>:</p>\n<p><strong>Shortened PR interval</strong>- because of the early initiation of ventricular depolarization</p>\n<p><strong>Prolonged QRS duration</strong>- because of the AV nodal impulse reaching the ventricles after the aberrant impulse.</p>\n<p><strong>Delta waves</strong>- slurred upstroke of QRS complex</p>\n<p>The given ECG shows delta waves marked with red arrows:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b00a7f28fc9540629f591281df010cf4x791x183.JPEG\" alt=\"Pearl Image\"><p><strong>Treatment:</strong></p>\n<ul>\n<li><strong>Catheter ablation</strong>&nbsp;is the treatment of choice.</li>\n<li>Anti-arrhythmic drugs like procainamide, amiodarone, quinidine, propafenone, dofetilide are used in slowing conduction in the accessory pathway (prolong refractory period).</li>\n<li>IV procainamide is the drug of choice in a hemodynamically stable WPW presenting with atrial fibrillation.</li>\n<li>DC cardioversion is done in&nbsp;hemodynamically unstable patients.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7512",
      "difficulty": "easy"
    },
    {
      "text": "A 40-year-old male patient came to ED with complaints of weakness, paresthesia, and breathing difficulty. Relevant investigations were done. The ECG obtained is suggestive of :",
      "choices": [
        {
          "id": 1,
          "text": "Hypokalemia"
        },
        {
          "id": 2,
          "text": "Hyperkalemia"
        },
        {
          "id": 3,
          "text": "Hypocalcemia"
        },
        {
          "id": 4,
          "text": "Hypercalcemia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The symptoms of <strong>weakness</strong>, <strong>paresthesia</strong>, and <strong>dyspnea</strong> along with the given ECG showing <strong>depression of the ST segment</strong>, a <strong>decrease</strong> in the <strong>amplitude of the T wave</strong> (flattening or inversion), and an <strong>increase</strong> in the <strong>amplitude of U waves</strong> (at the end of the T wave) are characteristic of <strong>hypokalemia</strong>.</p>\n<p>In the given ECG, leads <strong>V1-V6</strong> exhibit <strong>T wave inversion</strong>. <strong>U waves</strong> are well appreciated in leads <strong>V2-V5</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/09d37f9b803c4884b212dd2ecf00f5d1x579x242.PNG\" alt=\"Explanation Image\"><p>Hypokalemia leads to dynamic ECG changes. The image given shows the sequence of changes observed:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/43d8e68f32034b5f89f8fc630832db5ax1160x1999.PNG\" alt=\"Explanation Image\"><p><strong>Hypokalemia</strong> is defined as plasma K+ concentration of <strong>&lt;3.5meq/L</strong>. It can also cause premature atrial and ventricular beats, sinus bradycardia, paroxysmal atrial or junctional tachycardia, atrioventricular block, and ventricular tachycardia or fibrillation.</p>\n<p>Other options:</p>\n<p>Option B: <strong>Hyperkalemia</strong> causes <strong>tall peaked T waves</strong> with a <strong>shortened QT interval</strong>. There is a <strong>progressive lengthening </strong>of the<strong> PR interval</strong> and <strong>QRS duration</strong> with an <strong>increase</strong> in <strong>potassium</strong> levels, eventually leading to the <strong>disappearance</strong> of the <strong>P wave</strong>; and <strong>widening</strong> of the <strong>QRS complex</strong> to a sine wave pattern.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9098e14050d0450e930ed8a0748d75eex1279x1256.PNG\" alt=\"Explanation Image\"><p>Option C: <strong>Hypocalcemia</strong> causes <strong>prolongation</strong> of the <strong>QT interval</strong>. There is a <strong>lengthening</strong> of the <strong>ST segment</strong>, while the <strong>T wave</strong> (which correlates with the time for repolarization) remains <strong>unaltered</strong>.</p>\n<p>Option D: <strong>Hypercalcemia</strong> causes <strong>shortening </strong>of the<strong> QT interval</strong> and a <strong>decrease</strong> in the <strong>ST segment duration</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fabdf24ece0045a798a8cd7ec4a3785dx1280x1158.PNG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/4be120b48ee84610944b9b914589c798.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA8834",
      "difficulty": "medium"
    },
    {
      "text": "Osborn waves in ECG are seen in:",
      "choices": [
        {
          "id": 1,
          "text": "Hypothyroidism"
        },
        {
          "id": 2,
          "text": "Hypothermia"
        },
        {
          "id": 3,
          "text": "Hypocalcemia"
        },
        {
          "id": 4,
          "text": "Hypokalemia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Osborn waves are seen in <strong>hypothermia</strong>.</p>\n<p>Osborn waves can also be seen in <strong>severe hypothyroidism</strong> (Option A), but even in those cases, <strong>hypothermia</strong> is the <strong>reason</strong> for the appearance of Osborn waves. Therefore, hypothermia is the better answer here. </p>\n<p>It consists of an <strong>abrupt ascent</strong> right at the <strong>J point</strong> (the junctional point between the QRS complex and the ST segment) and then an equally sudden plunge back to the baseline. It is also called the <strong>J wave</strong>. This is because systemic hypothermia <strong>prolongs repolarisation</strong>. </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9d5ab690bb354af0b8b037e6150f8c4bx478x478.GIF\" alt=\"Explanation Image\"><p>Osborn wave can also be seen in:</p>\n<ul>\n<li>Hypercalcemia</li>\n<li>Brain injury</li>\n<li>Subarachnoid hemorrhage</li>\n<li>Vasospastic angina</li>\n<li>Cardiopulmonary arrest from oversedation</li>\n<li>Idiopathic ventricular fibrillation</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0232",
      "difficulty": "easy"
    },
    {
      "text": "The production of which of the following hormones is increased in obesity?",
      "choices": [
        {
          "id": 1,
          "text": "Insulin"
        },
        {
          "id": 2,
          "text": "Thyroxine"
        },
        {
          "id": 3,
          "text": "Growth hormone"
        },
        {
          "id": 4,
          "text": "Adiponectin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Insulin levels are increased in <strong>obesity</strong>. It stimulates the <strong>synthesis of fatty acids</strong> and <strong>TAG</strong> and <strong>decreases</strong> the rate of <strong>lipolysis</strong>. <strong>Thyroxine</strong>, <strong>growth hormone</strong>, and <strong>adiponectin</strong> have <strong>lipolytic effects</strong>, hence their levels are <strong>reduced</strong> in obesity.</p>\n<p><strong>Hyperinsulinemia</strong> and <strong>insulin resistance</strong> are consistent features of obesity. Insulin resistance is more strongly linked to intra-abdominal fat than to fat in other areas. </p>\n<p><strong>Adiponectin</strong> (Option D) is an <strong>anti-inflammatory cytokine</strong> that is produced by adipocytes. It performs vital functions that are reduced in obesity - like, <strong>increasing insulin sensitivity</strong> and the <strong>inhibition of gluconeogenic enzymes</strong>. It also enhances <strong>fatty acid oxidation</strong>. </p>\n<p><strong>Insulin resistance</strong> in obesity occurs as a result of the following:</p>\n<ul>\n<li>Insulin <strong>receptor downregulation</strong></li>\n<li><strong>Increased FFA</strong> (free fatty acids) and capable of impairing insulin action</li>\n<li>Intracellular lipid accumulation</li>\n<li><strong>Circulating peptides</strong> produced by adipocytes such as <strong>TNF-&alpha;</strong>, <strong>IL-6</strong>,<strong> RBP4</strong>, and <strong>resistin</strong> modify insulin action.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7038",
      "difficulty": "medium"
    },
    {
      "text": "What is the diagnosis of this patient from the ECG shown below?",
      "choices": [
        {
          "id": 1,
          "text": "Normal ECG"
        },
        {
          "id": 2,
          "text": "Ventricular fibrillation"
        },
        {
          "id": 3,
          "text": "Ventricular tachycardia"
        },
        {
          "id": 4,
          "text": "Misplaced leads"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The rate of the given ECG is around <strong>188 BPM</strong> ( &gt;100 BPM) and it shows <strong>wide QRS complexes</strong> ( &ge; 0.12 s) with <strong>abnormal morphology</strong> (red arrows) and <strong>absence of P waves</strong> which suggests a diagnosis of <strong>ventricular tachycardia</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/130beaa3b3b0476d8c21af66e5ee33f9x1280x184.PNG\" alt=\"Explanation Image\"><p>Ventricular fibrillation (Option B) would not show discreet QRS complexes, and hence is not the answer in this case.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/44acec8550be4ce0b208549b2e07bd54x800x179.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: ECG patterns of various ventricular arrhythmias</h3><p>Ventricular tachycardia</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/097b95729fa14ac68da475ce6288a968x1088x570.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p>Polymorphic ventricular tachycardia associated with QTc prolongation- Torsades de pointes</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a8ebe0b5757c4efca4f5dd15c6d24e99x1268x324.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p>Ventricular flutter</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/666962cd0f424000b7e84123f719f120x502x282.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p>Ventricular fibrillation</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/25067efa869941baa6a40b54599b371ax1049x213.PNG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/24692db0f660497cbbc53a7599250a3e.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0616",
      "difficulty": "medium"
    },
    {
      "text": "All are true about patients with trigeminal neuralgia except:",
      "choices": [
        {
          "id": 1,
          "text": "More common in females"
        },
        {
          "id": 2,
          "text": "Pain along V2 and V3 division of trigeminal nerve"
        },
        {
          "id": 3,
          "text": "Deep seated pain"
        },
        {
          "id": 4,
          "text": "No objective signs of sensory loss"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Trigeminal neuralgia is associated with <strong>superficial pain</strong>&nbsp;and <strong>not deep-seated pain</strong>.</p>\n<p>It is more <strong>common</strong> (~ 60% of cases) in <strong>females</strong> (Option A)<strong> over 50 years</strong> and is characterized by <strong>unilateral lancinating facial pain</strong>. This most commonly involves the <strong>second and/or third divisions</strong> (Option B) of the <strong>trigeminal nerve</strong> territory. <strong>Bilateral</strong> or<strong> early-onset pain</strong> is associated with <strong>multiple sclerosis</strong>. Unilateral trigeminal nerve compression can be due to the superior cerebellar artery.</p>\n<p>Pain is <strong>repetitive</strong>, severe, and brief and can be <strong>triggered by touch</strong>, <strong>cold</strong>, <strong>wind</strong>, or <strong>eating</strong>. Physical signs are usually absent, although the <strong>spasms</strong> may make the patient <strong>wince and sit silently</strong> <strong>(tic douloureux)</strong>. <strong>No</strong> signs of <strong>sensory loss</strong> are present (Option D)</p>\n<p>The drug of choice is <strong>carbamazepine</strong>.</p><p>Note: It is important to note that <strong>trigeminal neuralgia</strong> and <strong>trigeminal autonomic cephalalgia</strong> (TAC) are <strong>different</strong> entities. <strong>TAC</strong> is a group of <strong>primary headaches</strong> that include - <strong>cluster headaches</strong>, <strong>paroxysmal hemicrania</strong>, short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT)/short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA), and hemicrania continua.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2346",
      "difficulty": "medium"
    },
    {
      "text": "All of the following are features of Crohn’s disease except:",
      "choices": [
        {
          "id": 1,
          "text": "Transmural involvement"
        },
        {
          "id": 2,
          "text": "Lead pipe appearance"
        },
        {
          "id": 3,
          "text": "Rectal sparing"
        },
        {
          "id": 4,
          "text": "Perianal fistula"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Lead pipe appearance</strong> is seen in <strong>ulcerative colitis</strong> (not Crohn's disease). This appearance is due to the<strong> loss of haustra</strong> in the diseased colonic segment.</p>\n<p>The image below shows the lead pipe appearance of the colon on barium enema: </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8499810b84f6457c9cbb9ff6bc8f2518x1280x1562.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Inflammatory Bowel Disease (IBD)</h3><p> </p>\n<table>\n<tbody>\n<tr>\n<td> </td>\n<td><strong>Crohn's disease</strong></td>\n<td><strong>Ulcerative colitis</strong></td>\n</tr>\n<tr>\n<td><strong>Age of onset </strong></td>\n<td>2nd-4th decades &amp; 7th-9th decades</td>\n<td>2nd-4th decades &amp; 7th-9th decades </td>\n</tr>\n<tr>\n<td><strong>Most common presentation</strong></td>\n<td>Ileocolitis with rectal sparing</td>\n<td>Proctitis (rectum)</td>\n</tr>\n<tr>\n<td><strong>Protective factors</strong></td>\n<td> None </td>\n<td>\n<p>Smoking </p>\n<p>Appendicectomy</p>\n</td>\n</tr>\n<tr>\n<td><strong>Risk factors</strong></td>\n<td>\n<p>OCP</p>\n<p>Smoking</p>\n<p>Antibiotic during first year of life </p>\n</td>\n<td>\n<p>α-Methyldopa</p>\n<p>Antibiotic during first year of life</p>\n</td>\n</tr>\n<tr>\n<td><strong>T cell involved</strong></td>\n<td>TH1 </td>\n<td>TH2</td>\n</tr>\n<tr>\n<td><strong>Gross findings/ endoscopic findings</strong></td>\n<td>\n<p>Transmural involvement</p>\n<p>Segmental involvement</p>\n<p>Skip lesions</p>\n<p>Cobblestone appearance</p>\n<p>Creeping fat</p>\n<p>Longitudinal ulcers</p>\n</td>\n<td>\n<p>Mucosal and superficial submucosal involvement </p>\n<p>Continuous involvement</p>\n<p>Pseudopolyps </p>\n<p>Backwash ileitis </p>\n<p>Collar button ulcers</p>\n</td>\n</tr>\n<tr>\n<td><strong>Earliest finding</strong></td>\n<td>Aphthous ulcer</td>\n<td>Erythematous mucosa with a fine granular surface</td>\n</tr>\n<tr>\n<td><strong>Microscopic findings </strong></td>\n<td>\n<p class=\"p1\">Deep, knife-like ulcers</p>\n<p>Granulomas</p>\n<p>Pyloric metaplasia  </p>\n</td>\n<td>\n<p class=\"p1\">Superficial, broad-based</p>\n<p>Cryptitis and crypt abscess </p>\n<p> </p>\n</td>\n</tr>\n<tr>\n<td><strong>Complications </strong></td>\n<td>\n<p>Fistulas </p>\n<p>Strictures</p>\n</td>\n<td>\n<p>Hemorrhage</p>\n<p>Toxic megacolon</p>\n</td>\n</tr>\n<tr>\n<td><strong>Recurrence after resection</strong></td>\n<td>\n<p>Common</p>\n</td>\n<td>\n<p>Uncommon, curative after resection</p>\n</td>\n</tr>\n<tr>\n<td><strong>Radiological findings </strong></td>\n<td>\n<p>Aphthous ulcer</p>\n<p>Rose thorn appearance</p>\n</td>\n<td>\n<p>Mucosal granularity</p>\n<p>Lead pipe appearance</p>\n</td>\n</tr>\n<tr>\n<td><strong>Extraintestinal manifestations</strong></td>\n<td colspan=\"2\">\n<div class=\"page\" title=\"Page 807\">\n<div class=\"page\" title=\"Page 807\">\n<div class=\"page\" title=\"Page 807\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Episcleritis, uveitis </p>\n<p>Migratory polyarthritis</p>\n<p>Ankylosing spondylitis, sacroiliitis</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<div class=\"page\" title=\"Page 807\">\n<div class=\"page\" title=\"Page 807\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Erythema nodosum</p>\n<p>Pyoderma gangrenosum- MC in UC</p>\n<p>Primary sclerosing cholangitis- MC in UC</p>\n<p>Renal Calculi- MC in CD</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><br /><br /></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1297",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is the most common type of Guillian-Barre syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Acute motor axonal neuropathy"
        },
        {
          "id": 2,
          "text": "Acute inflammatory demyelinating polyneuropathy"
        },
        {
          "id": 3,
          "text": "Acute motor sensory axonal neuropathy"
        },
        {
          "id": 4,
          "text": "Miller Fisher syndrome"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Acute inflammatory demyelinating</strong> <strong>polyneuropathy (AIDP)</strong> is the most common type of GBS.</p>\n<p>There are several <strong>types of Guillain&ndash;Barre syndrome,</strong> which are recognized by electrodiagnostic studies and pathological distinctions. These include:</p>\n<p>A. Demyelinating</p>\n<ul>\n<li><strong>Acute inflammatory demyelinating polyneuropathy</strong> (AIDP) - most common</li>\n</ul>\n<p>B. Axonal</p>\n<ul>\n<li><strong>Acute motor axonal neuropathy</strong> (AMAN)</li>\n<li><strong>Acute motor&ndash;sensory axonal neuropathy</strong> (AMSAN)</li>\n</ul>\n<p>C. Regional GBS syndromes</p>\n<ul>\n<li><strong>Miller&ndash;Fisher syndrome</strong> (MFS)</li>\n<li>Pure sensory forms</li>\n<li>Ophthalmoplegia with anti-GQ1b antibodies as part of severe motor-sensory GBS</li>\n<li>GBS with severe bulbar and facial paralysis</li>\n<li>Acute pandysautonomia</li>\n</ul><hr><h3>Related Pearl: Antibodies seen in Guillian Barre syndrome</h3><table>\n<tbody>\n<tr>\n<td><strong>Type</strong></td>\n<td><strong>Antibody</strong></td>\n</tr>\n<tr>\n<td>AIDP</td>\n<td>Anti GM1</td>\n</tr>\n<tr>\n<td>AMAN</td>\n<td>Anti GD1a</td>\n</tr>\n<tr>\n<td>AMSAN</td>\n<td>Anti GD1a</td>\n</tr>\n<tr>\n<td>Miller Fisher syndrome</td>\n<td>Anti GQ1b</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li>AIDP-Acute inflammatory demyelinating polyneuropathy&nbsp;</li>\n<li>AMAN-Acute motor axonal neuropathy&nbsp;</li>\n<li>AMSAN-Acute motor sensory axonal neuropathy&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB7556",
      "difficulty": "easy"
    },
    {
      "text": "Cushing’s ulcers are seen in",
      "choices": [
        {
          "id": 1,
          "text": "Burns"
        },
        {
          "id": 2,
          "text": "Stress"
        },
        {
          "id": 3,
          "text": "Head injury"
        },
        {
          "id": 4,
          "text": "Cell necrosis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Cushing&rsquo;s ulcers</strong> are seen in patients with <strong>head injury</strong>. They can also be seen in cases of <strong>space-occupying lesions</strong>, such as <strong>intracranial tumors</strong>. The most common areas affected are the <strong>acid-producing areas</strong> of the <strong>stomach</strong> <strong>(fundus and body)</strong>.</p>\n<p><strong>Stress ulcers</strong> observed in severe <strong>burns</strong> patients are called <strong>Curling&rsquo;s ulcers</strong>. They are usually seen in the <strong>duodenal mucosa</strong> and are related to reduced perfusion and ischemia.</p>\n<p>Stress-related gastric ulcers are seen in patients with massive burns, severe shock, sepsis, or head injury. Inflammatory mediators released in these conditions result in gastric mucosal inflammation. The most <strong>common presentation</strong> is minimal <strong>GI bleeding</strong>. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7484",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is true about paroxysmal nocturnal hemoglobinuria?",
      "choices": [
        {
          "id": 1,
          "text": "Inherited defect in PIG –A"
        },
        {
          "id": 2,
          "text": "Extravascular hemolysis"
        },
        {
          "id": 3,
          "text": "Deficiency of CD 55 and CD 59"
        },
        {
          "id": 4,
          "text": "Microcytic anaemia"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Deficiency of <strong>CD55</strong> and <strong>CD59</strong> is seen in <strong>paroxysmal nocturnal hemoglobinuria</strong> (PNH).</p>\n<p>It is due to an <strong>acquired mutation</strong> in the <strong>X-linked</strong> phosphatidylinositol class A <strong>PIG-A gene</strong> (Option A) causing a <strong>deficiency</strong> of <strong>GPI anchor proteins</strong>. GPI is a glycolipid that <strong>anchors membrane protective factors</strong> such as CD59 and CD55 to the membrane. The deficiency of CD55 and CD59 makes the <strong>RBC </strong>sensitive to <strong>complement-mediated intravascular hemolysis</strong>(Option B). The <strong>anemia</strong> is usually <strong>normo-macrocytic</strong> (Option D).</p>\n<p><strong>Hemolysis</strong> tends to occur at <strong>night</strong> due to a slight <strong>decrease in blood pH</strong> during sleep, which triggers complement activity (nocturnal hemoglobinuria). <strong>PNH</strong> is characterized by <strong>hemolytic anemia</strong>, <strong>pancytopenia</strong>, and <strong>venous thrombosis</strong>.</p>\n<p>PNH is diagnosed using <strong>flow cytometry</strong>. The drugs of choice for treatment are <strong>Eculizumab</strong> or <strong>Ravulizumab</strong> which work against <strong>complement C5</strong>. Supportive management of PNH includes <strong>folic acid</strong> and <strong>iron supplementation</strong>. Bone marrow transplantation is another option for the treatment of this condition. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4364",
      "difficulty": "medium"
    },
    {
      "text": "A patient with rheumatoid arthritis is being treated with methotrexate and low-dose corticosteroids for the past 4 months. However, the disease is still progressing. What would be your recommendation for the further management of this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Stop oral methotrexate and start parenteral methotrexate"
        },
        {
          "id": 2,
          "text": "Add sulfasalazine and hydroxychloroquine"
        },
        {
          "id": 3,
          "text": "Continue corticosteroids and methotrexate"
        },
        {
          "id": 4,
          "text": "Start only anti-TNF alpha agents"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>For further management of a patient with <strong>rheumatoid arthritis</strong> (RA) with <strong>worsening disease</strong> activity, the preferred therapy is a step-up to <strong>oral triple therapy</strong> with <strong>methotrexate</strong>, <strong>sulfasalazine</strong>, and <strong>hydroxychloroquine</strong>. The addition of leflunomide or a biological (anti - TNF) to methotrexate is another alternative.</p>\n<p>Ideally, the approach to a patient with early RA is aggressive. <strong>Methotrexate</strong> is always the <strong>first DMARD</strong> that the patient is started on, and if an <strong>adequate response</strong> is <strong>not</strong> <strong>observed</strong> within <strong>3-6 months</strong>, a step up in therapy is made by <strong>adding on drugs</strong>. </p>\n<p>For <strong>assessment of progression</strong>, composite indices like <strong>Disease Activity Score</strong> <strong>- 28</strong> (DAS-28) can used. </p><p>Other options:</p>\n<p>Option A: Changing the route of administration of methotrexate from oral to parenteral is not a part of step up&nbsp;</p>\n<p>Option C: Priority is given to minimising the duration the patient is on steroids.</p>\n<p>Option D: <strong>Anti -TNF agents</strong> (adalimumab, etanercept) are <strong>not recommended</strong> as a <strong>monotherapy</strong>, and are reserved for treatment in <strong>combination with DMARDs</strong>. This is due to the fact that the <strong>efficacy of monotherapy</strong> is <strong>lesser than</strong> that of <strong>DMARDs</strong>, and the adverse effects include increased risk of serious infections, re-activation of latent TB and opportunistic fungal infections. They are reserved for cases where there is a lack of response with the first line agents.&nbsp;</p><hr><h3>Related Pearl: Important drugs for rheumatoid arthritis</h3><p><strong>1) NSAIDs - </strong>analgesic and anti-inflammatory, used as <strong>adjunctive</strong> for management of uncontrollable <strong>symptoms</strong> and in acute <strong>flares.</strong></p>\n<p dir=\"ltr\"><strong>2) Glucocorticoids - </strong>used in acute <strong>flare</strong> for rapid control and as <strong>initial therapy</strong> before the onset of action of DMARDs. Chronic administration of low doses is needed in patients with inadequate response to DMARDs.</p>\n<ul>\n<li dir=\"ltr\">\n<p>Prednisolone - oral</p>\n</li>\n<li dir=\"ltr\">\n<p>Triamcinolone - intraarticular<br /> </p>\n</li>\n</ul>\n<p><strong><span>3) DMARDs - </span></strong><span>disease-modifying anti-rheumatoid drugs:</span></p>\n<p> </p>\n<p><strong>- Conventional DMARDs:</strong></p>\n<ul>\n<li dir=\"ltr\">Methotrexate (MTX)- is an antifolate drug. The DMARD of <strong>choice</strong> and the anchor drug for combination therapy. Regular <strong>LFT</strong> monitoring is required.</li>\n<li dir=\"ltr\">Hydroxychloroquine- is used as <strong>monotherapy</strong> for <strong>early</strong> and <strong>mild</strong> disease and in combination with other DMARDs for severe cases.</li>\n<li dir=\"ltr\">Sulfasalazine- is a salicylate. It <strong>reduces</strong> the radiographic <strong>progression</strong> of the disease.</li>\n<li dir=\"ltr\">Leflunomide- is a pyrimidine synthase inhibitor used as an <strong>alternative</strong> to MTX.</li>\n</ul>\n<p><span><strong>- Biologicals:</strong></span></p>\n<ul>\n<li>TNF-α antagonists- used in combination with MTX. Has a risk of serious bacterial infections, opportunistic fungal infection &amp; reactivation of latent TB. The TNF-α inhibitors are <strong>adalimumab,</strong> golimumab, etanercept, infliximab, and certolizumab.</li>\n<li>Abatacept- a T-cell costimulation inhibitor, used in combination with MTX, leflunomide, etc.</li>\n<li>Rituximab- an <strong>anti-CD20</strong> antibody. Used in refractory disease in combination with MTX.</li>\n<li>Anakinra- an<strong> IL-1</strong> receptor <strong>antagonist</strong>. It should not be combined with anti-TNF alpha.</li>\n<li><strong>IL-6</strong> receptor <strong>antagonists</strong>- tocilizumab and sarilumab are used as monotherapy or combination therapy in moderate to severe disease.  </li>\n</ul>\n<p><span><strong>- Small molecules: </strong></span></p>\n<ul>\n<li>Janus kinase inhibitors: <strong>Tofacitinib</strong>, baricitinib, and upadacitinib are used as monotherapy or combination therapy.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7585",
      "difficulty": "easy"
    },
    {
      "text": "A lady presents with fever, oral ulcers, photosensitivity, and rashes on her face as shown below. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Dermatomyositis"
        },
        {
          "id": 2,
          "text": "Systemic lupus erythematosus"
        },
        {
          "id": 3,
          "text": "Rosacea"
        },
        {
          "id": 4,
          "text": "Melasma"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical case describes a young lady with <strong>fever</strong>, <strong>oral ulcers</strong>, and <strong>photosensitivity</strong>. The image shows a <strong>well-demarcated erythematous butterfly-shaped rash</strong> over the <strong>malar eminences</strong> with <strong>sparing of the nasolabial folds</strong> (malar rash). The clinical presentation along with the image showing malar rash point to a diagnosis of <strong>systemic lupus erythematosus</strong> (SLE).</p>\n<p>The diagnosis of SLE is based on the presence of clinical and immunological manifestations.</p>\n<p>Clinical manifestations:</p>\n<ol>\n<li>Skin: <strong>Acute, subacute cutaneous</strong> manifestations (<strong>photosensitivity</strong>, malar or <strong>maculopapular rash</strong>) and <strong>Chronic cutaneous</strong> manifestations (<strong>discoid lupus</strong>, panniculitis, lichen planus-like)</li>\n<li><strong>Oral</strong> or <strong>nasal ulcers</strong></li>\n<li>Non-scarring<strong> alopecia</strong></li>\n<li><strong>Synovitis</strong> involving <strong>&ge;2 joints</strong></li>\n<li>Serositis (pleurisy, pericarditis)</li>\n<li>Renal: Protein/Creatinine ratio &gt;0.5; RBC casts; &gt; Class II lupus nephritis on renal biopsy</li>\n<li>Neurologic: seizures, psychosis, myelitis, neuropathy, confusional state</li>\n<li>Hemolytic anemia</li>\n<li>Leukopenia (&lt;4,000/mcL)</li>\n<li>Thrombocytopenia (&lt;1,00,000/mcL)</li>\n</ol>\n<p>Immunological manifestations:</p>\n<ol>\n<li><strong>Antinuclear antibodies</strong> &gt;reference value (positive in &gt;98% patients)</li>\n<li><strong>Anti-dsDNA</strong> &gt;reference value (<strong>specific</strong>)</li>\n<li>Anti-Smith antibody (specific)</li>\n<li>Antiphospholipid antibody (lupus anticoagulant, false-positive rapid plasma reagin)</li>\n<li>Low serum complement (C3, C4)</li>\n</ol><p>According to the <strong>Systemic Lupus International Collaborating Clinics</strong> (SLICC) criteria, at least <strong>4 out of 11</strong> of the above criteria must be positive with at least <strong>one clinical</strong> and <strong>one immunological criteria</strong> well <strong>documented</strong> to <strong>diagnose SLE</strong>. However, if a <strong>renal biopsy</strong> is suggestive of <strong>lupus nephritis</strong> and <strong>lupus autoantibodies are positive</strong>, other criteria are not required.</p>\n<p><strong>Life-threatening</strong> manifestations include - <strong>lupus nephritis</strong> leading to end-stage renal disease, <strong>myocarditis</strong>, <strong>venous and arterial thrombosis</strong> (including stroke and myocardial infarction), <strong>ARDS</strong>, and <strong>vasculitis</strong> involving the gastrointestinal vasculature - leading to ischemia, bleeding, and sepsis.</p>\n<p>NOTE: There are two classifications systems used to diagnose SLE:</p>\n<ul>\n<li><strong>SLICC criteria</strong>, which mentions the clinical features is easier to use for clinical diagnosis.</li>\n<li><strong>EULAR/ACR criteria</strong> which apply weightage to each clinical manifestation. The patient must have a <strong>positive ANA antibody titre of &gt;1:80</strong> by <strong>immunofluorescence</strong>, and a score of 10 to be diagnosed. The EULAR criteria is more recent and is commonly used for clinical studies.</li>\n</ul><hr><h3>Related Pearl: Key Chart to help differentiate lesions on face</h3><p><strong>Key Chart to help Differentiate Lesions on face</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0a5140c64ee04126a3fec16990765703x1280x2116.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p>The following images show the findings in -</p>\n<ul>\n<li><strong>Melasma</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1b24d22d7e6a4de493c0d240ebd6ec77x512x379.PNG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<ul>\n<li><strong>Rosacea</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0b3b7051b30c4603b4fc56b6170151f5x484x237.PNG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<ul>\n<li>Butterfly-shaped malar rash in<strong> SLE&nbsp;</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/96558496ccf84739a55a7acab31585ffx512x584.PNG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<ul>\n<li><strong>Acne</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/22d3e7b84f47471a8b58f938dc1a03f2x640x480.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8897f6677285496484b6281ce6100c65x640x427.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/20f4612e49014dcbb32ac3481718547fx640x480.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f248bc3b24f94e969561e2bf7be0b6b7x800x536.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<ul>\n<li><strong>Nevus of Ota</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0f16c38775234b8789ab421ee8988755x512x494.PNG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<ul>\n<li><strong>Portwine stain</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2ff136c533da46809a1e8615c5c9afa2x1280x959.5486600846262.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<ul>\n<li><strong>Infantile hemangioma</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/828bdd67837445a583f2c34441ecc984x450x600.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Antibodies in Systemic lupus erythematosus (SLE)</h3><table>\n<tbody>\n<tr>\n<td><strong>Antibody</strong></td>\n<td><strong>Prevelance %</strong></td>\n<td><strong>Antigen Recognized</strong></td>\n<td><strong>Clinical utility</strong></td>\n</tr>\n<tr>\n<td>Antinuclear Antibody</td>\n<td>98</td>\n<td>Multiple nuclear</td>\n<td>Best screening test; repeated -ve test make SLE unlikely</td>\n</tr>\n<tr>\n<td>Anti dS-DNA</td>\n<td>70</td>\n<td>DNA(double stranded)</td>\n<td>High titres are SLE specific &amp; in some patients correlates  with disease activity, nephritis &amp; vasculitis</td>\n</tr>\n<tr>\n<td>Anti-Sm</td>\n<td>25</td>\n<td>Protein complexed to 6 species of nuclear U1 RNA</td>\n<td>Specific for SLE; no definite correlations; most patients also have anti RNP <br />More common in black &amp; asians than white</td>\n</tr>\n<tr>\n<td>Anti-RNP</td>\n<td>40</td>\n<td>Protein complexed to U1 RNA</td>\n<td>Not Specific for SLE; high titre associated with syndromes that have overlap features of several rheumatic syndromes including SLE;<br />More common in blacks and whites </td>\n</tr>\n<tr>\n<td>Anti-Ro( SS-A)</td>\n<td>30</td>\n<td>Protein complexed to hY RNA,<br />Primarily 60kDA and 52kDA</td>\n<td>Not Specific for SLE; associated with sicca syndrome, predisposes to subacute cutaneous lupus &amp; to neonatal lupus with congenital heart block; associated with decrease risk of nephritis</td>\n</tr>\n<tr>\n<td>Anti-La( SS-B)</td>\n<td>10</td>\n<td>47kDa protein complexed to hY RNA</td>\n<td>Usually associated with anti-RO, associated with decreased  risk for nephritis</td>\n</tr>\n<tr>\n<td>Antihistone</td>\n<td>70</td>\n<td>Histones associated with DNA<br />(In nucleosome &amp; chromatin)</td>\n<td>More frequent in drug induced lupus than in SLE</td>\n</tr>\n<tr>\n<td>Antiphospholipid</td>\n<td>50</td>\n<td>Phospholipid,β2 glycoprotein1(β2 G1) cofactor , prothrombin</td>\n<td>3 tests available-ELISAs for cardiolipin &amp; β2 G1,<br />Sensitive prothrombin time (DRVVT)<br />Predisposes to clotting, fetal loss, thrombocytopenia</td>\n</tr>\n<tr>\n<td>Antierythrocyte</td>\n<td>60</td>\n<td>Erythrocyte membrane </td>\n<td> Measured as direct Coombs test , a small proportion devlop overt hemolysis</td>\n</tr>\n<tr>\n<td>Antiplatelet</td>\n<td>30</td>\n<td>Surface &amp; altered cytoplasmic antigens on platelets</td>\n<td>Associated with thrombocytopenia, but sensitivity &amp; specificity are not good:<br />This is not a useful clinical test</td>\n</tr>\n<tr>\n<td>Antineuronal<br />(includes antiglutamate receptor)</td>\n<td>60</td>\n<td>Neuronal &amp; lymphocyte surface antigens</td>\n<td>In some series, a positive test in CSF correlates with active CNS lupus</td>\n</tr>\n<tr>\n<td>Antiribosomal P</td>\n<td>20</td>\n<td>Protein in ribosomes</td>\n<td>In some series, a positive test serum correlates with depression or psychosis due to CNS lupus</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/a5c9c1e2f54d4cc4887154176f62bab6.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7577",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following murmur increases on standing?",
      "choices": [
        {
          "id": 1,
          "text": "HOCM"
        },
        {
          "id": 2,
          "text": "MR"
        },
        {
          "id": 3,
          "text": "MS"
        },
        {
          "id": 4,
          "text": "VSD"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The murmur of hypertrophic cardiomyopathy (HOCM) <strong>increases with standing</strong>, as there is a reduction in preload. In conditions of reduced preload, there is lesser end diastolic volume in the left ventricle, leading to a narrower outflow tract, and a louder murmur is heard.</p>\n<p>The <strong>murmur</strong> heard in <strong>HOCM</strong> is a <strong>mid-systolic&nbsp;murmur</strong>, which is <strong>loudest</strong> along the <strong>left sternal border</strong>. It <strong>increases</strong> in conditions of <strong>decreased preload and afterload</strong> (standing, valsalva, vagal maneuvers) or conditions of <strong>increased contractility</strong> (inotropic stimulation) and <strong>decreases</strong> when <strong>preload and afterload</strong> are <strong>increased</strong> (squatting, vasopressors).</p>\n<p>Most murmurs decrease in intensity with reduced preload and afterload except HOCM and mitral valve prolapse (MVP). </p><hr><h3>Related Pearl: Dynamic auscultation of murmurs</h3><table>\n<tbody>\n<tr>\n<td><strong>Bedside Manoeuvre</strong></td>\n<td><strong>Effect</strong></td>\n</tr>\n<tr>\n<td>\n<p>Inspiration</p>\n<p>(&uarr;venous return to right atrium)</p>\n</td>\n<td>\n<ul>\n<li>&uarr; intensity of right-sided sounds</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Handgrip</p>\n<p>(&uarr;afterload )</p>\n</td>\n<td>\n<ul>\n<li>&uarr; intensity of MR, AR, and VSD murmurs</li>\n<li>&darr; hypertrophic cardiomyopathy and AS murmurs</li>\n<li>MVP: delayed onset of click/murmur</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Valsalva-Phase II, standing up</p>\n<p>(&darr; preload)</p>\n</td>\n<td>\n<ul>\n<li>&darr; intensity of most murmurs (including AS)</li>\n<li>&uarr;&nbsp;intensity of hypertrophic cardiomyopathy murmur</li>\n<li>MVP: earlier onset of click /murmur</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Rapid squatting</p>\n<p>(&uarr;venous return,&uarr;preload,<br />&uarr; afterload)</p>\n</td>\n<td>\n<ul>\n<li>&darr;intensity of hypertrophic cardiomyopathy murmur</li>\n<li>&uarr;&nbsp;intensity of AS, MR, and VSD murmurs</li>\n<li>MVP: later onset of click/murmur</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7497",
      "difficulty": "easy"
    },
    {
      "text": "On performing a pulmonary function test, reduction in FEV1/FVC is characteristic of:",
      "choices": [
        {
          "id": 1,
          "text": "Restrictive disease"
        },
        {
          "id": 2,
          "text": "Obstructive disease"
        },
        {
          "id": 3,
          "text": "Normal lung function"
        },
        {
          "id": 4,
          "text": "Interstitial lung disease"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Reduction in FEV1/FVC is characteristic of <strong>obstructive lung disease</strong>.</p>\n<p><strong>Forced vital capacity</strong> (FVC) is the <strong>volume of expired air</strong> recorded when a person <strong>inhales to the total lung capacity</strong> and <strong>exhales</strong> <strong>as hard</strong> and as completely as possible. The <strong>volume of air expired</strong> in the <strong>first second</strong> is called the <strong>forced expiratory volume 1</strong> (FEV1).</p>\n<p>Given below is a graphical representation of FEV and FEV1:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8358ea027fde4213a61adf85ac982f84x1280x1110.JPEG\" alt=\"Explanation Image\"><p><strong>FVC</strong> is <strong>reduced</strong> in both <strong>obstructive</strong> and <strong>restrictive lung diseases</strong>. In <strong>obstructive</strong> diseases, the slope of FVC is <strong>steady</strong>, therefore the <strong>FEV1</strong> value is <strong>low</strong> and the <strong>FEV1/FVC ratio decreases</strong>. In <strong>restrictive</strong> diseases, the airflow is fast in the beginning leading to a <strong>higher value of FEV1</strong> and <strong>FEV1/FVC ratio increases</strong>.</p><hr><h3>Related Pearl: PFT for obstructive vs restrictive diseases</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>PFT</strong></p>\n</td>\n<td>\n<p><strong>Obstructive disease</strong></p>\n</td>\n<td>\n<p><strong>Restrictive disease</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>FVC</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n<td>\n<p>Decreased (&lt;80% predicted)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>FEV1</p>\n</td>\n<td>\n<p>Decreased (&lt;80% predicted)</p>\n</td>\n<td>Decreased</td>\n</tr>\n<tr>\n<td>\n<p>FEV1% (FEV1/FVC)</p>\n</td>\n<td>\n<p>Decreased (&lt;0.7)</p>\n</td>\n<td>\n<p>Normal/ increased (&gt;0.7)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>FEF 25-75</p>\n</td>\n<td>\n<p>&lt;50% predicted</p>\n</td>\n<td>\n<p>Normal/ decreased</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>TLC</p>\n</td>\n<td>\n<p>Normal/ increased</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>RV</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>DLCO</p>\n</td>\n<td>\n<ul>\n<li>Normal or increased in asthma</li>\n<li>Decreased in emphysema</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Decreased in intrinsic restrictive disease</li>\n<li>Normal in neuromuscular or musculoskeletal restrictive disease</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>FVC: Forced Vital Capacity</p>\n<p>FEV1: Forced expiratory volume in 1 second</p>\n<p>FEF 25-75: Forced expiratory flow at 25-75% vital capacity</p>\n<p>TLC: Total lung capacity</p>\n<p>RV: Residual volume</p>\n<p>DLCO: Diffusion capacity of lung for Carbon monoxide.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7501",
      "difficulty": "easy"
    },
    {
      "text": "Calcitonin levels are increased in:",
      "choices": [
        {
          "id": 1,
          "text": "Hyperthyroidism"
        },
        {
          "id": 2,
          "text": "Hypoparathyroidism"
        },
        {
          "id": 3,
          "text": "Hyperparathyroidism"
        },
        {
          "id": 4,
          "text": "Cushing's syndrome"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Calcitonin levels are increased in <strong>hyperparathyroidism</strong>. </p>\n<p>Due to <strong>elevated parathyroid hormone </strong>(PTH) levels in hyperparathyroidism, there is <strong>osteoclast activation</strong>. This leads to <strong>increased calcium</strong> levels in plasma. As a response to this, there is an <strong>increase</strong> in the level of <strong>calcitonin</strong> to regulate the high calcium levels.</p>\n<p><strong>Calcitonin</strong> is secreted by the parafollicular C-cells of the thyroid gland. Its principal effects are to lower serum calcium and phosphate by its action on bone and kidney. In <strong>bone</strong>, calcitonin <strong>inhibits osteoclasts</strong> and <strong>reduces bone resorption</strong>. In the <strong>kidney</strong>, it <strong>inhibits</strong> the <strong>reabsorption</strong> of both <strong>calcium and phosphate</strong>.</p><p>Other options</p>\n<p>Option A: In <strong>hyperthyroidism</strong>, the direct effect of thyroid hormones can lead to bone resorption and <strong>mild hypercalcemia</strong>. However, hyperparathyroidism is a better answer.</p>\n<p>Options B and D: <strong>Hypoparathyroidism</strong> and <strong>Cushing&rsquo;s syndrome</strong> will have <strong>low serum calcium</strong> and hence, will not have <strong>increased calcitonin</strong> levels.</p><hr><h3>Related Pearl: Biochemical parameters in metabolic bone diseases</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Metabolic bone disease</strong></p>\n</td>\n<td><strong>Calcium</strong></td>\n<td><strong>PTH</strong></td>\n<td><strong>Phosphate</strong></td>\n<td><strong>ALP</strong></td>\n</tr>\n<tr>\n<td>\n<p>Rickets / Osteomalacia</p>\n</td>\n<td>&nbsp;&darr;/N</td>\n<td>&nbsp; &nbsp;&uarr;</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&darr;</td>\n<td>&nbsp; &nbsp;&uarr;</td>\n</tr>\n<tr>\n<td>\n<p>Primary</p>\n<p>hyperparathyroidism</p>\n</td>\n<td>&nbsp; &nbsp; &nbsp;&uarr;</td>\n<td>&nbsp;&nbsp;&nbsp;&uarr;</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp;&darr;</td>\n<td>&nbsp;&uarr;</td>\n</tr>\n<tr>\n<td>\n<p>Secondary</p>\n<p>hyperparathyroidism</p>\n</td>\n<td>&nbsp; &nbsp; &nbsp;&darr;</td>\n<td>&nbsp;&nbsp; &uarr;</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp;&uarr;</td>\n<td>&nbsp; &nbsp; &uarr;</td>\n</tr>\n<tr>\n<td>\n<p>Tertiary hyperparathyroidism</p>\n</td>\n<td>&nbsp; &nbsp; &nbsp;&uarr;</td>\n<td>&nbsp; &nbsp; &uarr;</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp;&uarr;</td>\n<td>&nbsp; &nbsp;&uarr;</td>\n</tr>\n<tr>\n<td>Osteoporosis</td>\n<td>&nbsp; &nbsp; &nbsp;N</td>\n<td>&nbsp; &nbsp;N</td>\n<td>&nbsp; &nbsp; &nbsp; N</td>\n<td>&nbsp; N</td>\n</tr>\n<tr>\n<td>\n<p>Paget's&nbsp;disease</p>\n</td>\n<td>&nbsp; &nbsp; &nbsp;N</td>\n<td>&nbsp; &nbsp;N</td>\n<td>&nbsp; &nbsp; &nbsp; N</td>\n<td>&nbsp; &uarr;</td>\n</tr>\n<tr>\n<td>\n<p>Osteopetrosis</p>\n</td>\n<td>&nbsp; &darr;/N</td>\n<td>&uarr;/N</td>\n<td>&nbsp; &nbsp; &darr;/N</td>\n<td>&nbsp; N</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;&uarr;: Increased,&nbsp;&nbsp;&darr;: Decreased, N: Normal</p><hr><h3>Related Pearl: Causes of Hypercalcemia</h3><ul>\n<li><strong>Parathyroid</strong>-Related\n<ul>\n<li>Primary hyperparathyroidism\n<ul>\n<li>Adenoma(s)</li>\n<li>Multiple endocrine neoplasia</li>\n<li>Carcinoma</li>\n</ul>\n</li>\n<li>Lithium therapy</li>\n<li>Familial hypocalciuric hypercalcemia</li>\n</ul>\n</li>\n<li><strong>Malignancy</strong>-Related\n<ul>\n<li>Solid tumour with metastases (breast)</li>\n<li>Solid tumour with humoral mediation of hypercalcemia (lung, kidney)</li>\n<li>Hematologic malignancies (multiple myeloma, lymphoma, leukemia)</li>\n</ul>\n</li>\n<li><strong>Vitamin</strong> <strong>D</strong>&ndash;Related\n<ul>\n<li>Vitamin D intoxication</li>\n<li>&uarr; 1,25(OH)2D :\n<ul>\n<li>Sarcoidosis and other granulomatous diseases</li>\n<li>Impaired 1,25(OH)2D metabolism due to 24-hydroxylase deficiency</li>\n</ul>\n</li>\n<li>Associated with <strong>high bone turnover</strong>\n<ul>\n<li>Hyperthyroidism</li>\n<li>Immobilization</li>\n<li>Thiazides</li>\n<li>Vitamin A intoxication</li>\n<li>Fat necrosis</li>\n</ul>\n</li>\n<li>Associated with <strong>renal failure</strong>\n<ul>\n<li>Severe secondary hyperparathyroidism</li>\n<li>Aluminium intoxication</li>\n<li>Milk-alkali syndrome</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7487",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following does not lead to ARDS (Acute Respiratory Distress Syndrome) at the blood-lung interface?",
      "choices": [
        {
          "id": 1,
          "text": "Pneumonia"
        },
        {
          "id": 2,
          "text": "Fat embolism syndrome following femur shaft fracture"
        },
        {
          "id": 3,
          "text": "Sepsis"
        },
        {
          "id": 4,
          "text": "Transfusion-related lung injury"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Pneumonia leads to&nbsp;<strong>Acute Respiratory Distress Syndrome </strong>(ARDS) at the <strong>air&ndash;lung interface</strong> and not at the blood-lung interface.</p>\n<p>ARDS can be caused by direct lung injury at the air-lung interface and indirect lung injury at the blood-lung interface.</p>\n<p>Causes at the <strong>air-lung interface (direct injury)</strong>:</p>\n<ul>\n<li>Aspiration</li>\n<li>Toxic gas or smoke inhalation</li>\n<li>Near-drowning</li>\n<li><strong>Pneumonia</strong></li>\n<li>Pulmonary contusion</li>\n</ul>\n<p>Causes at the <strong>blood-lung interface</strong> <strong>(indirect injury)</strong>:</p>\n<ul>\n<li><strong>Sepsis</strong></li>\n<li><strong>Transfusion-related lung injury</strong> (TRALI)</li>\n<li>Pancreatitis</li>\n<li>Long bone fractures causing <strong>fat embolism syndrome</strong></li>\n<li>Thromboembolism</li>\n</ul><p><strong>ARDS</strong> is a clinical syndrome of <strong>rapid onset severe dyspnea</strong> within one week of known clinical insult, <strong>hypoxemia,</strong> and <strong>diffuse pulmonary infiltrates</strong> leading to respiratory failure.</p>\n<p>The recommended therapies in ARDS with clinical or supportive evidence include:</p>\n<ul>\n<li><strong>Low tidal volume ventilation</strong> (LTVV) strategy (4&ndash;6 mL/kg of ideal body weight) is recommended to maintain adequate ventilation and avoid ventilator-induced lung injury by barotrauma and volume trauma.</li>\n<li><strong>High positive end-expiratory pressure</strong> (PEEP) or open lung mechanical ventilation improves arterial oxygenation by improving ventilation perfusion mismatch.</li>\n<li>Prone position</li>\n<li><strong>Extracorporeal membrane oxygenation</strong> (ECMO)</li>\n<li>The routine use of <strong>glucocorticoids</strong> is <strong>not beneficial</strong>.</li>\n</ul>\n<p>The following X-ray shows bilateral alveolar infiltrates as seen in ARDS:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/abf9b3cc423140adb9e42a00cfe5a3a5x1280x1023.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8278",
      "difficulty": "medium"
    }
  ]
}